Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to Montreal, that boasts 30 years of experience in developing and manufacturing medicine. Maryse Laliberté, Halo Pharma’s vice-president and general manager, highlights the company’s differentiation factors of quality delivery and flexibility, and presents the company’s ambitions for the further international expansion of its business in Europe and Asia.
Maryse, can you please give us an introduction to Halo Pharma’s history and presence here in Mirabel?
"Our main differentiation factor remains our highly personal customer service and our willingness to accommodate our client’s needs."
